We are live on
!
Find out more
AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
1-Year Est. Return
117.01%
This Fund
S&P 500
This Quarter
Est. Return
-10.26%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$317M
AUM Growth
-$57.6M
(-15%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-6.81%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inseego
INSG
|
+$36.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$35.4M |
| 2 |
MacroGenics
MGNX
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 71.59% |
| 2 | Technology | 24.6% |
| 3 | Miscellaneous | 3.81% |
Similar funds
MFAM
SL
CIM
SFM
SFG
CGI
VFA
AMG
Aviva Holdings's Q4 2018 Portfolio in Review
As of Q4 2018, Aviva Holdings held 7 positions worth $317M, down 15% from $375M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Aviva Holdings withdrew a net $21.6M in Q4 2018, reducing 2 holdings. Its largest reduction was Esperion Therapeutics, cutting an estimated $35.4M.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 88% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Aviva Holdings added an estimated $36.1M to Inseego.
- Aviva Holdings added most to Inseego in Q4 2018, an estimated $36.1M increase.
- Aviva Holdings's biggest Q4 2018 reduction was Esperion Therapeutics, cutting an estimated $35.4M.
- Aviva Holdings's ten largest holdings make up 100% of its $317M portfolio in Q4 2018.
- Aviva Holdings opened 0 new positions and closed 0 in Q4 2018.
- Aviva Holdings's portfolio value fell 15% quarter-over-quarter to $317M.
Based on Aviva Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.